A maternal defect is responsible for growth failure in vitamin D-deficient rat pups.
Vitamin D deficiency was induced in lactating rats and their pups by placing female rats on a vitamin D-deficient diet immediately after mating. Evidence of vitamin D deficiency included undetectable plasma levels of 25-hydroxyvitamin D3 in the dams, maternal hypocalcemia, the lack of pup growth, and pup hypocalcemia following starvation. This method of producing vitamin D-deficient pups was then used to determine whether the failure of vitamin D-deficient pups to grow properly results from a maternal or neonatal defect. Vitamin D-deficient dams and pups were injected with either vitamin D3 or the ethanol vehicle, and pup growth was monitored over the subsequent 6 days. Providing vitamin D3 to the pups directly had no effect on their growth, but administering vitamin D3 to the dams resulted in a tripling of the pup growth rate. The failure of vitamin D3 to promote pup growth when given directly to the pups was not the result of their inability to metabolize the vitamin because these pups converted [3H]-vitamin D3 to 25(OH)D3, 24,25(OH)2D3, and 1,25(OH)2D3 as determined by comigration with standards on both straight and reverse phase high-performance liquid chromatography systems. These results demonstrate that a maternal defect is responsible for the growth failure observed in vitamin D-deficient rat pups.
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001835:Body Weight; D002112:Calcifediol / Q000097:blood; D002118:Calcium / Q000097:blood; D005260:Female; D006130:Growth Disorders / Q000209:etiology*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D051381:Rats / Q000254:growth & development*; D011919:Rats, Inbred Strains; D014807:Vitamin D / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000150:complications* / Q000188:drug therapy
D014807:Vitamin D; D002112:Calcifediol; D002118:Calcium